Citations

Mayo Clinic

Showing 10 of 108551 citations.

Perspectives on cellular senescence and short term dietary restriction in adults
Kirkland, James L.

Aging | March 6, 2016 | Volume: 2 | Issue: 9 | Pages: 542-544

10.18632/aging.100204 | PMID 20864777 Get It

Epidemiology of Mixed Connective Tissue Disease, 1985–2014: A Population‐Based Study
Ungprasert, Patompong , Crowson, Cynthia S. , Chowdhary, Vaidehi , Ernste, Floranne C. , Moder, Kevin G., Matteson, Eric L. , Chowdhary, Vaidehi R

Arthritis Care & Research | March 6, 2016 | Volume: 68 | Issue: 12 | Pages: 1843-1848

10.1002/acr.22872 | PMID 26946215 Get It

ObjectiveTo characterize the epidemiology of mixed connective tissue disease (MCTD) from 1983 to 2014.MethodsAn inception cohort of patients with incident MCTD in 1985–2014 in Olmsted County, Minnesota was identified based on comprehensive individual medical record review. Diagnosis of MCTD required fulfillment of at least 1 of the 4 widely accepted diagnostic criteria without fulfillment of classification criteria for other connective tissue diseases. Data were collected on demographic characteristics, clinical presentation, laboratory investigations, and mortality.ResultsA total of 50 incident cases of MCTD were identified (mean age 48.1 years and 84% were female). The annual incidence of MCTD was 1.9 per 100,000 population. Raynaud's phenomenon was the most common initial symptoms (50%), followed by arthralgia (30%) and swollen hands (16%). The diagnosis was frequently delayed with the median time from first symptom to fulfillment of criteria of 3.6 years. At fulfillment of criteria, arthralgia was the most prevalent manifestation (86%), followed by Raynaud's phenomenon (80%), swollen hands (64%), leukopenia/lymphopenia (44%), and heartburn (38%). Evolution to other connective tissue occurred infrequently with a 10‐year rate of evolution of 8.5% and 6.3% for systemic lupus erythematosus and systemic sclerosis, respectively. The overall mortality was not different from the general population with a standardized mortality ratio of 1.1 (95% confidence interval 0.4–2.6).ConclusionThis study was the first population‐based study of MCTD to provide a complete picture of epidemiology and clinical characteristics of MCTD. MCTD occurred in about 2 persons per 100,000 per year. Evolution to other connective diseases occurred infrequently and the mortality was not affected.
Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR−/− mice
Berryman, Darlene E. , Ikeno, Yuji , Hubbard, Gene B., Funk, Kevin, Comisford, Ross , Young, Jonathan A., Tchkonia, Tamar , Kirkland, James L. , Miller, Richard A. , Kopchick, John J. , List, Edward Owen , Young, Jonathan A., Stout, Michael B , Masternak, Michal M , Bartke, Andrzej , Tchkonia, T

Aging | March 5, 2016 | Volume: 7 | Issue: 7 | Pages: 500-512

10.18632/aging.100766 | PMID 26233957 Get It

Aspirin use and the risk of cholangiocarcinoma‡
Ghoz, Hassan , Peeraphatdit, Thoetchai , Baichoo, Esha, Addissie, Benyam D., Harmsen, William S. , Therneau, Terry M. , Chaiteerakij, Roongruedee , Roberts, Lewis R. , Choi, Jonggi, Ghoz, Hassan M, Choi, Jonggi , Olson, Janet E. , Chaiteerakij, Roongruedee , Roberts, Lewis R

Hepatology | March 5, 2016 | Volume: 64 | Issue: 3 | Pages: 785-796

10.1002/hep.28529 | PMID 26940227 Get It

Whether aspirin use is protective against cholangiocarcinoma (CCA) remains unclear. We determined the association between aspirin use and other risk factors for each CCA subtype individually. In a hospital‐based case‐control study, 2395 CCA cases (1169 intrahepatic, 995 perihilar, and 231 distal) seen at the Mayo Clinic, Rochester, MN, from 2000 through 2014 were enrolled. Controls selected from the Mayo Clinic Biobank were matched two to one with cases by age, sex, race, and residence (n = 4769). Associations between aspirin use, other risk factors, and CCA risk were determined. Aspirin was used by 591 (24.7%) CCA cases and 2129 (44.6%) controls. There was a significant inverse association of aspirin use with all CCA subtypes, with adjusted odds ratios (AORs) of 0.35 (95% confidence interval [CI], 0.29‐0.42), 0.34 (95% CI 0.27‐0.42), and 0.29 (95% CI 0.19‐0.44) for intrahepatic, perihilar, and distal CCA, respectively (P < 0.001 for all). Primary sclerosing cholangitis was more strongly associated with perihilar (AOR = 453, 95% CI 104‐999) than intrahepatic (AOR = 93.4, 95% CI 27.1‐322) or distal (AOR = 34.0, 95% CI 3.6‐323) CCA, whereas diabetes was more associated with distal (AOR = 4.2, 95% CI 2.5‐7.0) than perihilar (AOR = 2.9, 95% CI 2.2‐3.8) or intrahepatic (AOR = 2.5, 95% CI 2.0‐3.2) CCA. Cirrhosis not related to primary sclerosing cholangitis was associated with both intrahepatic and perihilar CCA, with similar AORs of 14. Isolated inflammatory bowel disease without primary sclerosing cholangitis was not associated with any CCA subtype. Conclusions: Aspirin use was significantly associated with a 2.7‐fold to 3.6‐fold decreased risk for the three CCA subtypes; our study demonstrates that individual risk factors confer risk of different CCA subtypes to different extents. (Hepatology 2016;64:785‐796)
Gastroesophageal junction carcinoma and brachial plexopathy: An anatomic explanation via perineural spread
Amrami, Kimberly K. , Spinner, Robert J. , Capek, Stepan

Clinical Anatomy | March 5, 2016 | Volume: 29 | Issue: 6 | Pages: 800-803

10.1002/ca.22708 | PMID 26940157 Get It

Long-Term Outcomes after Autologous Chondrocyte Implantation
Pareek, Ayoosh , Carey, James L. , Reardon, Patrick J., Peterson, Lars, Krych, Aaron J. , Stuart, Michael J. , Krych, Aaron J

CARTILAGE | March 4, 2016 | Volume: 7 | Issue: 4 | Pages: 298-308

10.1177/1947603516630786 | PMID 27688838 Get It

Objective Autologous chondrocyte implantation (ACI) has not been proven to be durable over the long-term. The purpose of this systematic review was (1) to evaluate activity level and knee function, (2) to evaluate reoperation and failure rates, and (3) to analyze risk factors for reoperation and failure of ACI at minimum long-term follow-up. Design A comprehensive review was performed for studies with long-term outcomes after ACI for cartilage defect repair. Studies reported outcome scores such as Tegner score, Lysholm score, and International Knee Documentation Society (IKDC) score along with rates of failure and reoperation. Modified Coleman Methodology Scores were calculated to assess study methodological quality. Results Nine studies with a total of 771 patients with a mean age of 33.4 ± 2.5 years, mean defect size of 5.9 ± 1.6 cm 2 , and mean follow-up of 11.4 years were included. Tegner score, Lysholm score, and IKDC score change from preoperative to final follow-up was 1.1 (95% CI 0.8-1.4, P < 0.001), 24.9 points (95% CI 18.8-31, P < 0.001), and 16.5 points (95% CI 5.4-27.5, P < 0.01), respectively. The mean failure and reoperation rates were 18% and 37%, respectively. Increased age and lesion size (>4.5 cm 2 ) were significantly correlated with increased risk of reoperation and failure. Conclusions Overall, ACI demonstrated successful outcomes in 82% of patients over the long-term. Increased patient age and lesion size greater than 4.5 cm 2 were risk factors for a higher reoperation and failure rate. Nonetheless, this review is limited by heterogeneity in surgical technique, and lesion and patient characteristics.
Osteosarcoma of the spine: prognostic variables for local recurrence and overall survival, a multicenter ambispective study
Dekutoski, Mark B. , Rose, Peter S. , Luzzati, Alessandro , Rhines, Laurence D. , Fisher, Charles G. , Chou, Dean , Fehlings, Michael G. , Reynolds, Jeremy , Williams, Richard P., Quraishi, Nasir A. , Germscheid, Niccole, Sciubba, Daniel M. , Gokaslan, Ziya L., Boriani, Stefano , _, _, Reynolds, Jeremy , Rose, Peter, Clarke, Michelle J. , Varga, Péter , _, _, Fehlings, Michael G , Reynolds, Jeremy

Journal of Neurosurgery: Spine | March 4, 2016 | Volume: 25 | Issue: 1 | Pages: 59-68

10.3171/2015.11.spine15870 | PMID 26943248 Get It

OBJECTIVE Primary spinal osteosarcomas are rare and aggressive neoplasms. Poor outcomes can occur, as obtaining marginal margins is technically demanding; further Enneking-appropriate en bloc resection can have significant morbidity. The goal of this study is to identify prognostic variables for local recurrence and mortality in surgically treated patients diagnosed with a primary osteosarcoma of the spine. METHODS A multicenter ambispective database of surgically treated patients with primary spine osteosarcomas was developed by AOSpine Knowledge Forum Tumor. Patient demographic, diagnosis, treatment, perioperative morbidity, local recurrence, and cross-sectional survival data were collected. Tumors were classified in 2 cohorts: Enneking appropriate (EA) and Enneking inappropriate (EI), as defined by pathology margin matching Enneking-recommended surgical margins. Prognostic variables were analyzed in reference to local recurrence and survival. RESULTS Between 1987 and 2012, 58 patients (32 female patients) underwent surgical treatment for primary spinal osteosarcoma. Patients were followed for a mean period of 3.5 ± 3.5 years (range 0.5 days to 14.3 years). The median survival for the entire cohort was 6.7 years postoperative. Twenty-four (41%) patients died, and 17 (30%) patients suffered a local recurrence, 10 (59%) of whom died. Twenty-nine (53%) patients underwent EA resection while 26 (47%) patients underwent EI resection with a postoperative median survival of 6.8 and 3.7 years, respectively (p = 0.048). EI patients had a higher rate of local recurrence than EA patients (p = 0.001). Patient age, previous surgery, biopsy type, tumor size, spine level, and chemotherapy timing did not significantly influence recurrence and survival. CONCLUSIONS Osteosarcoma of the spine presents a significant challenge, and most patients die in spite of aggressive surgery. There is a significant decrease in recurrence and an increase in survival with en bloc resection (EA) when compared with intralesional resection (EI). The effect of adjuvant and neoadjuvant chemotherapeutics, as well as method of biopsy, requires further exploration.
Management of Hypoparathyroidism: Summary Statement and Guidelines
Brandi, Maria Luisa , Bilezikian, John P. , Shoback, Dolores , Bouillon, Roger , Thakker, Rajesh V. , Khan, Aliya , Potts, John T. , Clarke, Bart L, Khan, Aliya A, Clarke, B.L. , Brandi, Maria Luisa , Thakker, Rajesh V

The Journal of Clinical Endocrinology & Metabolism | March 4, 2016 | Volume: 101 | Issue: 6 | Pages: 2273-2283

10.1210/jc.2015-3907 | PMID 26943719 Get It

Abstract Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent or deficient PTH. This report presents a summary of current information about epidemiology, presentation, diagnosis, clinical features, and management and proposes guidelines to help clinicians diagnose, evaluate, and manage this disorder. Participants: Participants in the First International Conference on the Management of Hypoparathyroidism represented a worldwide constituency with acknowledged interest and expertise in key basic, translational, and clinical aspects of hypoparathyroidism. Three Workshop Panels were constituted to address questions for presentation and discussion at the Conference held in Florence, Italy, May 7–9, 2015. At that time, a series of presentations were made, followed by in-depth discussions in an open forum. Each Workshop Panel also met in closed sessions to formulate the three evidence-based reports that accompany this summary statement. An Expert Panel then considered this information, developed summaries, guidelines, and a research agenda that constitutes this summary statement. Evidence: Preceding the conference, each Workshop Panel conducted an extensive literature search as noted in the individual manuscripts accompanying this report. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Consensus Process: This report represents the Expert Panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of hypoparathyroidism. Conclusions: This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of hypoparathyroidism.
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Ding, Xiwei , Chaiteerakij, Roongruedee , Moser, Catherine D., Shaleh, Hassan M., Boakye, Jeffrey, Ndzengue, Albert, Zhou, Yanling , Huang, Shengbing, Thomas, Melanie B., Smith, Charles D. , Roberts, Lewis R. , Shaleh, Hassan, Chen, Gang , Chaiteerakij, Roongruedee , Li, Ying , Sinicrope, Frank A. , Zou, Xiaoping , Roberts, Lewis R

Oncotarget | March 4, 2016 | Volume: 7 | Issue: 15 | Pages: 20080-20092

10.18632/oncotarget.7914 | PMID 26956050 Get It

Faculty Opinions recommendation of Evaluation of screening for retinopathy of prematurity by roptool or a lay reader.
Brodsky, Michael C., Grigorian, Paula

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 4, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726022651.793515075 Get It